140 related articles for article (PubMed ID: 14603099)
1. Atazanavir (Reyataz) and emtricitabine (Emtriva) for HIV infection.
Med Lett Drugs Ther; 2003 Nov; 45(1169):90-2. PubMed ID: 14603099
[No Abstract] [Full Text] [Related]
2. Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes.
Prescrire Int; 2009 Jun; 18(101):104. PubMed ID: 19637415
[TBL] [Abstract][Full Text] [Related]
3. The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.
Chetchotisakd P
Expert Rev Anti Infect Ther; 2009 Sep; 7(7):801-5. PubMed ID: 19735222
[TBL] [Abstract][Full Text] [Related]
4. [Medication change due to side effects or possible long-term complications. Side effect management with vision].
Sankawa Y
MMW Fortschr Med; 2009 Apr; 151(18):35. PubMed ID: 19769072
[No Abstract] [Full Text] [Related]
5. 96-week CASTLE data show similar efficacy results.
AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
[No Abstract] [Full Text] [Related]
6. [New data on atazanavir/r]].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():81-3. PubMed ID: 16385887
[No Abstract] [Full Text] [Related]
7. Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.
Poirier JM; Guiard-Schmid JB; Meynard JL; Bonnard P; Zouai O; Lukiana T; Jaillon P; Girard PM; Pialoux G
AIDS; 2006 Apr; 20(7):1087-9. PubMed ID: 16603872
[No Abstract] [Full Text] [Related]
8. [Evidence-based therapeutic drug monitoring of atazanavir].
Solas C; Muret P;
Therapie; 2011; 66(3):213-9. PubMed ID: 21819805
[TBL] [Abstract][Full Text] [Related]
9. Drug profile: atazanavir (Reyataz, ATV).
Pham PA
Hopkins HIV Rep; 2003 Jul; 15(4):4-5. PubMed ID: 14696562
[No Abstract] [Full Text] [Related]
10. FDA notifications. Reyataz is approved for HIV treatment.
AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
[TBL] [Abstract][Full Text] [Related]
11. A truvada hypersensitivity reaction simulating abacavir hypersensitivity.
de Perio MA; Gomez FJ; Frame PT; Fichtenbaum CJ
AIDS; 2007 Oct; 21(16):2252-3. PubMed ID: 18090057
[No Abstract] [Full Text] [Related]
12. Atazanavir: new option for treatment of HIV infection.
Havlir DV; O'Marro SD
Clin Infect Dis; 2004 Jun; 38(11):1599-604. PubMed ID: 15156449
[TBL] [Abstract][Full Text] [Related]
13. Atazanavir.
Orrick JJ; Steinhart CR
Ann Pharmacother; 2004 Oct; 38(10):1664-74. PubMed ID: 15353575
[TBL] [Abstract][Full Text] [Related]
14. Atazanavir (Reyataz): new recommendations if combined with tenofovir (Viread) -- and warning on Viagra, Cialis, and Levitra.
AIDS Treat News; 2004 Mar; (399):5. PubMed ID: 15199867
[TBL] [Abstract][Full Text] [Related]
15. Boosted Reyataz: 48-week results.
Huff B
GMHC Treat Issues; 2004; 18(1-2):15. PubMed ID: 15119279
[No Abstract] [Full Text] [Related]
16. Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient.
Cattaneo D; Meraviglia P; Cozzi V; Baldelli S; Milani G; Clementi E
Fundam Clin Pharmacol; 2012 Apr; 26(2):204-6. PubMed ID: 21210843
[TBL] [Abstract][Full Text] [Related]
17. [Determination of serum levels of antiretroviral drugs].
Kurowski M
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():62-4. PubMed ID: 15373053
[No Abstract] [Full Text] [Related]
18. [Atazanavir protects lipid metabolism. New PI with favorable metabolic profile].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():90. PubMed ID: 15373065
[No Abstract] [Full Text] [Related]
19. Elevated alkaline phosphatase with raltegravir in a treatment experienced HIV patient.
Fleischbein E; O'Brien J; Martelino R; Fenstersheib M
AIDS; 2008 Nov; 22(17):2404-5. PubMed ID: 18981785
[No Abstract] [Full Text] [Related]
20. Anti-HIV agents. Atazanavir and raltegravir--an interesting combination.
TreatmentUpdate; 2009; 21(3):3-4. PubMed ID: 19623725
[No Abstract] [Full Text] [Related]
[Next] [New Search]